tradingkey.logo
搜索

Embecta Corp

EMBC
添加自选
3.350USD
-0.010-0.30%
收盘 07/02, 13:00美东报价延迟15分钟
198.75M总市值
1.75市盈率 TTM

Embecta Corp

3.350
-0.010-0.30%
查看详细走势图
TradingKey 图表
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

-0.30%

5天

-4.01%

1月

-1.76%

6月

-71.27%

今年开始到现在

-71.80%

1年

-67.54%

关键数据
3.420今开
3.420最高
1.85M成交量
1.75市盈率 TTM
2.00市盈率动
0.600股息TTM
3.12%换手率
3.360昨收
3.310最低
4.21M成交额
2.08市盈率静
-0.32市净率
17.91%股息率 TTM
10.41%ROA
15.55052周最高
1.09量比
95.40M净利润
59.33M总股本
1.9092每股收益TTM
1.09Beta
--ROE
8.47052周最低
3.27%振幅
56.45%毛利率
198.75M总市值
-0.44回报/风险
3.34%风险率

TradingKey Embecta Corp股票评分

单位: USD 更新时间: 2026-07-02

操作建议

Embecta Corp当前公司基本面数据相对健康,增长潜力很大。当前估值合理,在医疗设备与耗材行业排名87/204位。机构持股占比非常高,近一月多位分析师给出公司评级为持有。最高目标价10.00。中期看,股价处于下降通道。近一个月,市场表现一般,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

Embecta Corp评分

相关信息

行业排名
87 / 204
全市场排名
200 / 4565
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
看空

Embecta Corp亮点

亮点风险
Embecta Corp. is a global medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. The Company has a portfolio of marketed products, including a variety of pen needles, syringes and safety injection devices. Its pen needles are sterile, single-use, medical devices, designed to be used in conjunction with pen injectors that inject insulin or other diabetes medications. It also sells safety pen needles, which have shields on both ends of the cannula that automatically deploy after the injection to help prevent needlestick exposure and injury during injection and disposal. Its traditional and safety pen needles are compatible and frequently used with pen injectors in the market. It sells sterile, single-use insulin syringes, which are used to inject insulin drawn from insulin vials. It also sells safety insulin syringes. It distributes its products through a variety of channels, including retail, hospitals and pharmacies.
利润高增长
公司净利润处于行业前列,最新年度总收入1.08B美元
高分红
公司属于高分红公司,最新股息支付率38.36%
估值低估
公司最新PE估值1.75,处于3年历史低位
机构减仓
最新机构持股59.40M股,环比减少7.24%
唐纳德·亚克特曼持仓
明星投资者唐纳德·亚克特曼持仓,最新持仓市值9.87M

分析师目标

根据 4 位分析师
持有
评级
10.000
目标均价
+197.62%
涨幅空间

Embecta Corp新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Embecta Corp简介

Embecta Corp. is a global medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. The Company has a portfolio of marketed products, including a variety of pen needles, syringes and safety injection devices. Its pen needles are sterile, single-use, medical devices, designed to be used in conjunction with pen injectors that inject insulin or other diabetes medications. It also sells safety pen needles, which have shields on both ends of the cannula that automatically deploy after the injection to help prevent needlestick exposure and injury during injection and disposal. Its traditional and safety pen needles are compatible and frequently used with pen injectors in the market. It sells sterile, single-use insulin syringes, which are used to inject insulin drawn from insulin vials. It also sells safety insulin syringes. It distributes its products through a variety of channels, including retail, hospitals and pharmacies.
公司代码EMBC
公司Embecta Corp
CEOKurdikar (Devdatt)
网址https://www.embecta.com/

常见问题

Embecta Corp(EMBC)的当前股价是多少?

Embecta Corp(EMBC)的当前股价是 3.35。

Embecta Corp的股票代码是什么?

Embecta Corp的股票代码是EMBC。

Embecta Corp股票的52周最高点是多少?

Embecta Corp股票的52周最高点是15.55。

Embecta Corp股票的52周最低点是多少?

Embecta Corp股票的52周最低点是8.47。

Embecta Corp的市值是多少?

Embecta Corp的市值是198.75M。

现在Embecta Corp(EMBC)的股票是买入、持有还是卖出?

根据分析师评级,Embecta Corp(EMBC)的总体评级为signal_hold,目标价格为10.00。

Embecta Corp(EMBC)股票的每股收益(EPS TTM)是多少

Embecta Corp(EMBC)股票的每股收益(EPS TTM)是1.64。